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Previous diffusion tensor imaging (DTI) studies have shown white matter pathology in
amyotrophic lateral sclerosis (ALS), predominantly in the motor pathways. Further these
studies have shown that DTI can be used longitudinally to track pathology over time,
making white matter pathology a candidate as an outcome measure in future trials. DTI
has demonstrated application in group studies, however its derived indices, for example
fractional anisotropy, are susceptible to partial volume effects, making its role questionable
in examining individual progression. We hypothesize that changes in the white matter are
present in ALS beyond the motor tracts, and that the affected pathways and associated
pattern of disease progression can be tracked longitudinally using automated diffusion
connectometry analysis. Connectometry analysis is based on diffusion spectrum imaging
and overcomes the limitations of a conventional tractography approach and DTI. The
identiﬁed affected white matter tracts can then be assessed in a targeted fashion using
High deﬁnition ﬁber tractography (a novel white matter MR imaging technique). Changes
in quantitative and qualitative markers over time could then be correlated with clinical
progression. We illustrate these principles toward developing an imaging biomarker for
demonstrating individual progression, by presenting results for ﬁve ALS patients, including
with longitudinal data in two. Preliminary analysis demonstrated a number of changes
bilaterally and asymmetrically in motoric and extramotoric white matter pathways. Further
the limbic system was also affected possibly explaining the cognitive symptoms in ALS. In
the two longitudinal subjects, the white matter changes were less extensive at baseline,
although there was evidence of disease progression in a frontal pattern with a relatively
spared postcentral gyrus, consistent with the known pathology in ALS.
Keywords: diffusion spectrum imaging, amyotrophic lateral sclerosis, white matter, longitudinal, motoric,
extramotoric
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative dis-
order, marked by progressive failure of both upper (UMN) and
lowermotor neurons (LMN). LMNsymptoms inALSmayobscure
the UMN symptoms, contributing at least partly to the poten-
tial delay in diagnosis and the subsequent treatment. An imaging
biomarker would therefore be useful for diagnostic and moni-
toring purposes, especially for evaluating efﬁcacy of treatments
in future trials. Previous diffusion tensor imaging (DTI) studies
have shown white matter pathology in ALS, predominantly in the
motor pathways. Further these studies have shown that DTI can
be used longitudinally to track pathology over time, making white
matter pathology a candidate as an outcome measure in future tri-
als. DTI (Jacob et al., 2003; Graham et al., 2004; Sach et al., 2004;
Nickerson et al., 2009; Iwata et al., 2011; van der Graaff et al., 2011;
Menke et al., 2012) studies in ALS have therefore been carried
out to investigate the involvement of the white matter tracts and
their potential correlation with clinical markers of progression
like the revised ALS functional rating scale (ALSFRS-R; Cedar-
baum et al., 1999; Brooks et al., 2000). These studies have relied
on DTI-based indices [like fractional anisotropy (FA) or apparent
diffusion coefﬁcient (ADC)] for quantiﬁcation of the observed
changes in the integrity of white matter tracts. Corticospinal tract
(CST) or corpus callosum (CC) have been of particular inter-
est. In general, these studies have demonstrated a reduction in
the values of FA, when compared to controls or when carried
out in a longitudinal fashion (Jacob et al., 2003; Sage et al., 2007;
Nickerson et al., 2009; Keil et al., 2012) over time along the CST.
These studies have indirectly demonstrated disease progression in
ALS. FA is a commonly used DTI-derived quantitative measure of
anisotropy (Basser and Pierpaoli, 1996; Oouchi et al., 2007) and
has been applied in the evaluation of white matter integrity in
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multiple neurological disease states including multiple sclerosis
(Guo et al., 2002) and stroke (Thomalla et al., 2004). It has been
suggested that the changes in FA may reﬂect changes in orga-
nization of ﬁbers (Beaulieu, 2002) with a reduction reﬂecting
axonal ﬁber degeneration and myelin breakdown in the central
and peripheral nervous system (Beaulieu et al., 1996; Ciccarelli
et al., 2006).
It is noteworthy that extramotoric changes have been demon-
strated in multiple ALS studies, including in CC (Filippini et al.,
2010); cingulum and hippocampal formation (Raaphorst et al.,
2011) and cerebellum (Keil et al., 2012). One pathological study
in ALS (Smith, 1960), based on post-mortem examination of
seven patients, showed evidence of degenerating ﬁbers in the pre-
central gyrus (and CST), postcentral gyrus and in the adjacent
frontal and parietal gyri, CC and basal ganglia. These changes
suggest a multisystem neurodegenerative process. DTI and voxel
based analysis (VBA) have been used in a complementary fashion
to elucidate these changes to varying extents (Sage et al., 2007;
van der Graaff et al., 2011; Rose et al., 2012; Verstraete et al.,
2013). Although these studies have been promising in demon-
strating white matter changes in ALS, DTI is acknowledged to
have major limitations. These limitations include inability to
represent the crossing of multiple ﬁbers, the absence of large seg-
ments of tracts and other minor artifacts (Alexander and Barker,
2005; Le Bihan et al., 2006). The indices derived from DTI, for
example FA, have been shown to suffer from the partial volume
effects, which lead to their underestimation in regions contain-
ing crossing ﬁbers (Alexander et al., 2001; Oouchi et al., 2007).
This therefore, limits the use of FA as a quantitative marker in
ALS. Other limitations pertinent to all tractography-based stud-
ies, are the inherent variability-particularly between observers in
the tracts due to issues related to the regions of interest (ROI)
chosen-and the manual nature of the analysis. VBA addresses
some of these limitations; however it does not provide direc-
tional information in terms of the speciﬁc tracts involved. Due
to these limitations, new ﬁber mapping techniques were devel-
oped such as high-angular-resolution diffusion imaging (HARDI;
Tuch et al., 2002) and diffusion spectrum imaging (DSI). DSI
measures diffusion spectra and enables resolution of intravoxel
heterogeneity of diffusion. This results in the resolution of a set
of directions of multiple pathways or ﬁber orientations within a
voxel (Wedeen et al., 2005) in contrast to the average direction
in DTI.
Our group has developed and demonstrated the use of an
advanced white matter imaging technique, high deﬁnition ﬁber
tractography (HDFT). HDFT addresses the limitations associ-
ated with DTI, and is accurate in tracking white ﬁber pathways in
the brain through complex ﬁber crossings to subcortical regions
and targets with subvoxel resolution (Fernandez-Miranda et al.,
2012). HDFT relies on DSI for acquisition (Wedeen et al., 2005);
generalized q-sampling imaging for ﬁber orientation estimation
(Yeh et al., 2010); multiple intravoxel sampling; and other inno-
vations in tractography (Verstynen et al., 2011). HDFT approach
has facilitated innovative studies on the structural connectivity
of several ﬁber tracts such as the middle longitudinal fasci-
cle (Wang et al., 2013); CST (Verstynen et al., 2011); CC (Jarbo
et al., 2012); dorsal stream visual pathways (Greenberg et al.,
2012); and the corticostriatal pathways (Verstynen et al., 2012).
Application of HDFT has enabled us to replicate several known
neuroanatomical features, including claustrum, thalamic nuclei
segmentation and multiple ﬁber crossings at the centrum semio-
vale (Fernandez-Miranda et al., 2012). Ongoing trials at our
institution are examining its application in evaluating white ﬁber
pathology in other diseases, for example cavernomas and brain
tumors with promising preliminary results (Fernandez-Miranda
et al., 2012). Quantitative anisotropy (QA) is our novel quan-
titative imaging measure related to our white matter imaging
technique. QA is a measure of anisotropy of water with esti-
mated spin density. QA serves as a reliable stopping criterion
for ﬁber tracking and is essential toward demonstrating end-
point connectivity of functional regions (Yeh et al., 2010; Yeh
et al., 2013b). It overcomes some of the limitations of FA in
assessing the ﬁber integrity in areas with multiple crossing ﬁbers,
and is less sensitive to partial volume effects, as demonstrated
in our recent study (Yeh et al., 2013b). As a directionally speciﬁc
quantitative measure, it is ideal for longitudinally assessing ﬁber
integrity in motoric and extramotoric white matter pathways in
ALS patients.
Our speciﬁc hypotheses are as follows: changes in the white
matter are present in ALS patients beyond the motor tracts; com-
promise of structural integrity of the white matter tracts can be
demonstrated qualitatively and be indirectly measured by our
imaging quantitative markers; and ﬁnally progression in affected
white matter tracts correlates with clinical progression. Accord-
ingly, our speciﬁc aim is to identify and track the affected white
matter pathways and their longitudinal progression in a reliable
manner, using automated diffusion connectometry analysis. We
will then aim to further longitudinally evaluate identiﬁed affected
white matter tracts, using HDFT and a targeted tractography
approach. The latter will enable us to examine potential correla-
tion between associated quantitative parameters, such as changes
in QA and/or volume and clinical deterioration in ALS patients
over time, for example as measured by ALSFRS-R. The overall
aim using this methodology is to establish a reproducible imag-
ing biomarker, which can identify and track progression of white
matter changes in ALS patients.
METHODS
CLINICAL INCLUSION CRITERIA AND EVALUATION
We present our preliminary results with respect to ﬁve patients
recruited into the present study. Two patients with probable ALS;
two patients with probable ALS (laboratory supported) and one
with possible ALS (predominantly UMN signs) were included in
the present study. ALS patients were identiﬁed by the El-Escorial
criteria (Brooks et al., 2000). Two patients have been scanned lon-
gitudinally, while the other three have had a baseline scan only
with planned longitudinal scans in the future. Of two patients
with longitudinal scans, patients 1 and 2 underwent two scans
approximately 1 year and 6 months apart respectively.
Our study plan involves recruiting a total of 20 patients
with ALS, including the diagnostic categories, as deﬁned by the
revised El-Escorial criteria (Brooks et al., 2000) of clinically deﬁ-
nite; probable; probable-laboratory supported and possible ALS.
A smaller subset with primary lateral sclerosis (PLS; Gordon
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et al., 2006) will also be included. Over a period of 2 years,
these patients will undergo three scans, 6 months apart longi-
tudinally. Corresponding to each scan session, the patients will
also undergo extensive clinical evaluation and scoring including
that of ALSFRS-R (Brooks et al., 2000), frontotemporal dementia
assessment, forced vital capacity (FVC) and Ashworth spasticity
scale as part of an ALS multidisciplinary clinic. Clinical evalua-
tion will be carried out by two neurologists, with specialist interest
in neuromuscular disorders. 20 age-matched neurologically nor-
mal controls will also be scanned three times in a similar fashion,
in order to contribute to the matched template ﬁle for compari-
son for diffusion connectometry analysis. The data acquired from
scanning the controls will also allow a direct matched compari-
son for targeted tractography in terms of changes in QA and/or
volume for speciﬁc affected ﬁber tracts of interest, as identiﬁed by
the connectometry analysis. Approval has been obtained from the
institutional review board (IRB#: REN12100240/PRO09010491).
TWO-STEP APPROACH TOWARD EVALUATING WHITE MATTER
DISEASE IN ALS
We propose and have currently adopted a two-step approach to
evaluating white matter disease in a longitudinal fashion in ALS
patients with the ﬁrst primary step involving diffusion connec-
tometry (Yeh et al., 2013a) analysis to identify the affected white
matter tracts followed by a detailed tractography approach toward
the evaluation of these identiﬁed abnormal ﬁber pathways. Diffu-
sion connectometry (Yeh et al., 2013a) is a fully automatic method
for examining ﬁber tracts. It uses the diffusionMRI data of normal
subjects as a norm to statistically examinepathwayswithdeviant or
abnormal connectivity in affected individuals. We have previously
demonstrated its utility in seven patients with chronic stroke and
compared the results with lesions shown on T2-weighted images;
ADC and FA maps as well as clinical manifestations. The results
were noteworthy in demonstrating that the affected tracts revealed
by connectometry corresponded well with the stroke lesions, as
shown by the T2-weighted images and in revealing the entire
affected tracts (Yeh et al., 2013a). Overall it is away to identify tracts
with decreased or increased connectivity and tracking differences.
The conventional tractography approach relies on deﬁning tracts
before comparing the difference, thereby making it vulnerable to
issues related to crossing and branching patterns, reliability and
reproducibility. Diffusion connectometry overcomes these prob-
lems by ﬁnding the local difference in diffusion distribution ﬁrst
without initiating ﬁber tracking. This therefore, ﬁlters out regions
without a substantial difference, leaving only pertinent affected
regions for further analysis. This approach is more robust for a
number of reasons: (a) it has a higher chance of detecting real
differences, as the analysis relies on analyzing the difference in dif-
fusion pattern, close to the signal level of the scan; (b) the entire
process is fully automated, therefore related variability from man-
ual selection of the ROI is eliminated; and (c) the obtained results
can be statistically tested using the length of the affected tracks
as a threshold, as described later. Further details regarding this
methodology is provided in Yeh et al. (2013a). Diffusion connec-
tometry approach can be tailored to test both individual and group
data against a control population. Results from this approach can
then be examined further using a targeted tractography approach.
IMAGING DATA
Image acquisition and reconstruction
Diffusion spectrum imaging data was acquired on a 3T Tim Trio
System (Siemens, Erlangen, Germany) using a 32-channel coil. A
head stabilizerwas utilized to prevent headmotion. A43-min, 257-
direction DSI scan with a twice-refocused spin-echo planar imag-
ing sequence and multiple b values (repetition time = 9916 ms,
echo time= 157ms, voxel size= 2.4mm× 2.4mm× 2.4mm,ﬁeld
of view = 231 mm × 231 mm, maximum b-value = 7000 s/mm2)
was performed. For anatomical comparisons, we also included
a high-resolution anatomical image using a 9-min T1-weighted
axial magnetization-prepared rapid-acquisition gradient-echo
sequence (repetition time = 2110 ms, echo time = 2.63 ms,
ﬂip angle = 8◦, number of slices = 176, ﬁeld of view =
256 mm × 256 mm, voxel size = 0.5 mm × 0.5 mm × 1.0 mm).
In this study, we discarded any dataset that had head motion
greater than one voxel deviation across the long scanning time
(by comparing the ﬁrst b0 and last b0 image). For this preliminary
study, we only selected patients who tolerated the scanning time
well.
Diffusion spectrum imaging data is reconstructed with a gen-
eralized q-sampling imaging (Yeh et al., 2010) approach. The
orientation distribution functions were reconstructed to 642 dis-
crete sampling directions for each pixel and with a diffusion
distance scaling parameter of 1.2. The resulting reconstructed
orientation distribution function can cover 1.2 standard devia-
tions of the free water diffusion distance in the underlying voxel
(measured in micrometers). Similar acquisition parameters are
being used to acquire control data to create a more accurate
matched template ﬁle. Acquisition parameters for the template ﬁle,
used for the connectometry analysis for the preliminary results,
were detailed in previous publications, including in its previous
use in the stroke study (Yeh and Tseng, 2011; Yeh et al., 2013a).
The normal template, used for the current analysis (DSI studio:
http://dsi-studio.labsolver.org) was derived from the DSI data of
90 neurologically normal subjects (Yeh and Tseng, 2011).
Step 1: diffusion connectometry analysis (Yeh et al., 2013a)
Reconstructing spin distribution functions in a common space.
The diffusion data of each subject is reconstructed in a com-
mon stereotaxic space using q-space diffeomorphic reconstruction
(QSDR; Yeh and Tseng, 2011), a method that satisﬁes the conser-
vation of diffusible spins and can be applied to diffusion datasets.
QSDRuses diffusion signals to calculate the spin distribution func-
tion (SDF). The DSI data of a studied subject, for example an ALS
patient is also reconstructed by QSDR to obtain the SDFs in the
MNI space. Further details regarding the reconstruction of SDF in
a common space can be found in our original methodology paper
(Yeh et al., 2013a).
Constructing the affected tracks. To demonstrate the segment of
the tracks that are affected by ALS, we performed ﬁber tracking
on the local tract orientations with a percentile rank lower than 5
(Figures 2–5), where local tract orientations with diffusion quan-
tities (SDF values) lower than ﬁfth percentile rank are plotted with
directional colors (red: left–right, green: anterior–posterior, blue:
superior–inferior), and tracks propagate along those local tract
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orientations. The tracking is conducted using a deterministic ﬁber
tracking algorithm in the DSI Studio. The tracking begins from
each local ﬁber orientation as seeds and propagates until no orien-
tation is found in the propagation direction. A maximum turning
angle of 60◦ is used with a step size of 1 mm (i.e., half of the spa-
tial resolution in the template space). The obtained trajectories,
termed the affected tracks can be used to reveal the pathways with
decreased connectivity. It is noteworthy that only local tract ori-
entations with substantial loss in diffusion quantities are tracked.
The affected tracks reveal only affected segments of the entire track
pathways.
Length of affected tracks. We used the length of affected tracks
(unit in voxel distance) to differentiate meaningful ﬁndings from
random variations. The rationale behind it is that normal pop-
ulation may have false-positive affected tracks due to noise in
diffusion weighted images, but its effect tends to appear randomly
in space, resulting in fragmentation of the affected tracks. As a
result, the distribution of the length of the affected tracks (termed
length distribution) will be exponential since the concatenation of
randomly distributed local tract orientations can be viewed as a
Poisson process (Yeh et al., 2013a). In contrast, the true connectiv-
ity difference in patient group will continue along ﬁber pathways
and form longer affected tracks. Using length as an index, the dif-
ference between random effect and true connectivity difference
can be differentiated and statistically tested. We can select the
affected tracks with length greater than a threshold (termed length
threshold) as positive ﬁndings because these trajectories are most
likely related to the disease. A higher length threshold may ﬁlter
out most of the false discoveries but may not be sensitive enough
to detect subtle difference. The determination of the length thresh-
old is a trade-off between sensitivity and speciﬁcity. To determine
a reasonable value, we can quantify the Type 1 error of a length
threshold using false discovery rate (FDR).
Adaptation of the original methodology and calculation of false
discovery rate. The calculation of FDR requires the length dis-
tribution calculated from a group of subjects. In a previous
study (Yeh et al., 2013a) and here with the preliminary results,
we obtained the affected tracks of each patient by comparing
his/her data with those of 90 normal subjects (Yeh and Tseng,
2011). The length of affected tracks in all patients is accounted
to obtain the empirical length distributions for the patient group.
Similarly we can treat normal subjects as patients and apply the
same analysis to each of them by comparing his/her data with
those of the other 89 normal subjects to obtain the empirical
length distribution for the normal population. The difference in
the affected tracts between patient and normal subject groups
can be used to calculate the FDR of our ﬁndings in the ALS
patients (Yeh et al., 2013a). In step 1 (Figure 1), using a ﬁfth
percentile ranking, we regarded any affected track with length
>24 mm as related to ALS, giving us an FDR of 0.16. This means
that 16% of the affected tracks may be false discoveries. Length
threshold and the FDR provide a quantitative measurement of
sensitivity/speciﬁcity of a ﬁnding. In order to track longitudinal
data, we used the same FDR and length threshold to examine
the subsequent scan, with the hypothesis that any demonstrated
FIGURE 1 | Length threshold as defined by number of voxels in
relation to the “false discovery rate” (FDR; each voxel = 2 mm).
A length threshold of 24 mm corresponding to 12 voxels was chosen,
therefore leading to an FDR of 0.16.
progression in the affected tracts is an indirect marker of disease
progression.
Step 2: HDFT and targeted ﬁber tractography
Fiber tracking analysis. For the HDFT data, ﬁber tracking was
performed with DSI Studio. Tracts are generated with the use
of an orientation distribution function-streamlined version of
the ﬁber assignment by continuous tracking (FACT) algorithm
(Basser et al., 2000; Yeh et al., 2010). Fiber tracking is initiated by
randomly seeding the ROI and initiating tracking in the direction
of the most prominent ﬁber. Fiber progression continues with a
step size of 1.2 mm, minimum ﬁber length of 20 mm, and turn-
ing angle threshold of 65◦. For smoothing of the tracts, the next
directional estimate of each voxel is weighted by 20% of the pre-
vious moving direction and 80% by the incoming direction of the
ﬁber. The tracking terminates when the relative QA for the incom-
ing direction drops below a preset threshold or exceeds a turning
angle of 65◦. The QA termination threshold is adjusted on a per-
subject basis, so that the threshold allows consistent white matter
coverage in all subjects. This is critical for single-subject-based
tractography studies in which individual differences in coil sensi-
tivity and diffusion signal homogeneity can vary across subjects.
After tracking, all streamlines were saved and tract segmentation
performed inDSI Studio. TheQA threshold is kept constant across
the longitudinal scans for the same subject. Mean QA and volumes
(voxel wise) are then obtained for affected ﬁber tracts of interest,
identiﬁed fromconnectometry analysis for bothhemispheres. This
is followed by calculation of percentage changes in QA and vol-
ume across longitudinal scans in order to obtain quantitative data
with respect to progression in order to enable potential correla-
tion with markers of clinical progression. Obtained data was also
evaluated qualitatively in terms of obvious “thinning”of the tracts
in a cross-section or discontinuity in a tract segment.
RESULTS
STEP 1: DIFFUSION MRI CONNECTOMETRY ANALYSIS
In order to track progression with longitudinal data in patients
1 and 2, and for current non-longitudinal data in 3, 4, and
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5 we chose a length threshold of 24 mm (corresponding to
12 voxels), thus giving us an FDR of 0.16 (Figure 1) for the
observed affected tracts. This threshold was kept constant across
longitudinal scans to detect progressive changes with disease
evolution.
Patient 1
Results are presented for this 48-year-old patient with a diagnosis
of probable laboratory supported ALS (limb onset; predominant
LMN involvement) with respect to two scans acquired approxi-
mately 1 year apart. His symptoms started about 30 months before
the baseline scan with widespread fasciculations and left hand
weakness. He has no family history of neurological disease. Diffu-
sion connectometry analysis revealed the changes predominantly
at the baseline in posterior part of the CC (Figure 2A). A year
later (Figures 2B–C), these changes had progressed to include the
ﬁbers in the posterior limb of the internal capsule (IC) predom-
inantly, CST and frontal ﬁbers coursing toward the brainstem;
cingulum, and other areas. These changes were consistent with
multisystem neurodegeneration and frontal progression with dis-
ease evolution. The patient’s ALSFRS-R score decreased from 45
to 32 during this interval. Cortical end points of the involved
ﬁber tracts conﬁrmed relative sparing of the postcentral gyrus and
associated sensory ﬁbers (Figure 2D), consistent with known ALS
pathology.
Patient 2
Imaging results for this 62-year-old male patient with probable
ALS (bulbar onset with predominant bulbar involvement) with
respect to two scans carried out approximately 6 months apart
are presented. His symptoms started with dysarthria. The disease
duration at the time of the baseline scan was 12 months. He has no
family history of neurological disorders. At baseline (Figure 3A),
the affected white matter tracts were predominantly the anterior
and posterior parts of the CC and parts of the CST bilaterally.
CST was involved more caudally than in patient 1. At the second
scan, 6 months later (Figures 3B–C), the changes in white mat-
ter were more extensive involving the CC; corticostriatal ﬁbers;
ﬁbers in the posterior limb of IC, including CST and the frontal
ﬁbers coursing toward the brainstem; cingulum and parts of the
superior longitudinal (SLF) and inferior occipito-frontal fasciculi
(IOF) bilaterally. These ﬁndings were more pronounced on the
left side. Over the scan interval, his ALSFRS-R score dropped
from 44 to 43. Cortical terminations of the affected ﬁbers, as
in patient 1 showed frontal progression with disease evolution
(Figure 3D).
Patient 3
This 62-year-old male patient with probable ALS (limb onset),
has undergone a single scan, so far 24 months into his disease
onset, characterized by left hand weakness and foot drop. He has
FIGURE 2 | (A) Baseline diffusion connectometry analysis for patient 1,
demonstrated the affected areas as being inferior occipito-frontal fasciculus
(Inf. Occ. Fr.), cingulum (Cing.), and posterior part of the corpus callosum
(CC). (B, posterior view) and (C, lateral view) a year later, extensive changes
are now evident bilaterally in the corpus callosum; cinguli and posterior limb
of the internal capsule (Int. Cap.) and in parts of inferior occipito-frontal
fasciculi. (D) Cortical end-points of the affected ﬁber tracts at the time of the
second scan demonstrate involvement of ﬁbers originating from precentral
gyrus (Precent. gyr.) and frontal areas with relative sparing of postcentral
gyrus (Postcent. gyr.).
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FIGURE 3 | (A) Baseline diffusion connectometry analysis for patient 2,
demonstrated the affected areas as being parts of the corpus callosum (CC),
corticospinal (Cort-sp.) tracts, and inferior occipito-frontal (Inf. Occ. Fr.)
fasciculi bilaterally. (B, left lateral view) and (C, posterior view) 6 months later
shows extensive bilateral changes now involving corticospinal tracts, frontal
ﬁbers coursing toward the brainstem in the posterior limb of the internal
capsule (Int. Cap.); cinguli (Cing.); superior longitudinal (Sup. Long.); and
inferior occipito-frontal fasciculi. (D) Cortical end points for the second scan
display predominant involvement of ﬁbers originating from the precentral
gyrus (Precent. gyr.) and frontal areas.
no family history of neurological disorders. The baseline scan
demonstrated extensive involvement of the CC; CST; SLF; IOF;
and cingulum bilaterally. The changes were more pronounced on
the right. There was also evidence of involvement of left superior
cerebellar peduncle (Figure 4). ALSFRS-R score at baseline scan
was 43.
Patient 4
A 62-year-old with probable ALS-laboratory supported (limb
onset with predominant UMN involvement) was 38 months into
her disease onset at her baseline scan. ALSFRS-R score was 40 at
the time of the baseline scan. Her initial symptoms were clumsi-
ness of the left foot and leg. Therewas no family history of ALS,but
mother hadAlzheimer’s disease. Diffusion connectometry analysis
(Figure 5A) demonstrated changes in motoric and extramotoric
tracts. As observed with other patients, changes were seen bilat-
erally (right > left) in CST, CC, cingulum, parts of SLF, and IOF
(Figure 5A).
Patient 5
A 74-year-old female has possibleALS (bulbar onset with predom-
inant UMN signs and bulbar involvement). Her symptoms started
about 27 months before the baseline scan with dysarthria. She has
no family history of neurological diseases. Baseline scan demon-
strated similar changes, as in patient 4 with more pronounced
involvement of the tracts on the right side. There was however
FIGURE 4 | Baseline scan (posterior view) in patient 3, demonstrating
evidence of extensive motoric and extramotoric changes in the white
matter tracts [corpus callosum (CC); internal capsule (IC); Superior
longitudinal (Sup. Long.) fasciculus; Cingulum (Cing.)] with changes
being more pronounced on the right; also noted was involvement of
the left superior cerebellar peduncle (Sup. Cereb.).
a greater rostro-caudal involvement of the CST, with associated
involvement of the cerebellar outﬂow tracts bilaterally (Figure 5B).
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FIGURE 5 | Baseline scans in patients 4 (A, left lateral view) and
5 (B, posterior view) demonstrating bilateral changes in the
motoric and extramotoric pathways, being more pronounced on
the right. Bilateral involvement of the cerebellar outﬂow tracts
(Cerebel. outﬂow) was noted in patient 5. Bilaterally involved tracts
in both included corpus callosum (CC); corticospinal tract (Cort-sp.);
frontal ﬁbers in the posterior limb of the internal capsule (Int. Cap.)
coursing toward the brainstem; cinguli (Cing.) and parts of superior
longitudinal (Sup. Long.) and inferior occipito-frontal (Inf. Occ. Fr.)
fasciculi.
STEP 2: TARGETED FIBER TRACKING USING HDFT OF AFFECTED TRACTS
FROM DIFFUSION CONNECTOMETRY
Using patients 1 and 2 with longitudinal scans, we calculated the
changes in QA and volumes for selected major white matter tracts,
affected through majority of their course and as identiﬁed from
the connectometry analysis (Table 1). As an example for patient
1, we selected CST for closer evaluation using changes in QA and
volume over 1 year scan interval. With similar tracking parameters
andQA threshold for the two scans, there was progressive compro-
mise of the CST bilaterally (Figure 6; right CST). This was seen
qualitatively by presence of discontinuity in its caudal part and
quantitatively by percentage decreases in QA for the left and right
at 25% and 28% respectively and associated percentage volume
reductions at 5% and 41% respectively.
DISCUSSION
In her paper published, Smith (1960) aimed to study the degen-
eration of myelinated ﬁber tracts in ALS. She demonstrated wider
extramotor involvement, including frontal cortex in addition to
the CST and CC. Further involvement of ﬁbers projecting to
the thalami and basal ganglia were also noted. In this remark-
able early study (Smith, 1960) pathological involvement of both
motoric and extramotoric whitematter pathways inALSwas high-
lighted. We can now demonstrate these patterns in vivo using
MR-based tractography techniques. White matter involvement is a
subject of investigation in both longitudinal and non-longitudinal
DTI studies in ALS toward assessing its use as a diagnostic
tool, including in distinguishing between different phenotypes
based on UMN versus LMN involvement and in monitoring
progression.
Longitudinal studies are useful toward demonstrating the time
course and progression of pathology in ALS. A longitudinal study
involving 24 subjects with ALS demonstrated a decrease in the FA
in the CST and frontal areas on a second scan, obtained 6 months
later (Keil et al., 2012). The progressive FA decrease along the CST
correlated with disease duration and the decrease in ALSFRS-R
(Keil et al., 2012). Similarly another study with 6 months follow-
up showedDTI abnormalities extending into bilateral frontal lobes
(Senda et al., 2011). van der Graaff et al. (2011) examined the
three phenotypes, i.e., ALS, PLS and progressive muscular atrophy
Table 1 | Changes in quantitative markers in two patients with longitudinal scans for major affected white matter tracts, as identified by the
connectometry analysis.
Patient number (scan interval) Percentage changes* in quantitative markers Affected major white matter tracts
L CST R CST CC L cingulum R cingulum
1 (12 months) QA −25% −28% −20% −23% +16%
Volume −5% −41% −86% −73% −71%
2 (6 months) QA −15% −17% +5% −4% +8%
Volume −61% −72% −67% −78% −39%
*: the percentage changes denote a decrease (−) in all cases except those denoted by the sign (+), where an increase was noted; CST, corticospinal tract; CC, corpus
callosum; L, left; R, right; QA, quantitative anisotropy.
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FIGURE 6 |Targeted fiber tracking in patient 1 demonstrated evidence of progressive compromise of the right corticospinal tract (Cort-sp.) between
the baseline scan (A) and the subsequent scan (B), a year later, on which discontinuity (discon.) in the caudal segment was noted.
(PMA) within the motor neuron disease (MND) spectrum. This
study assessed the upper- and extra-motoneuron white matter
involvement shortly after diagnosis by comparing DTI data of
the different cohorts to those of healthy controls and by directly
comparing disease phenotypes. Follow-up data was also acquired
6 months later to evaluate FA changes over time. Diffusion ten-
sor tractography of the CST and whole-brain VBA was utilized
to ascertain the white matter involvement in MND. VBA demon-
strated white matter involvement to varying extents in different
phenotypes although in quite similar anatomical locations. In
general, FA reductions were found to be most extensive in PLS
with the observation of both upper motor and extra-motoneuron
involvement in all phenotypes of MND shortly after diagnosis.
VBA was more sensitive in detecting longitudinal changes than
tractography of the CST. VBA was also thought to be particularly
valuable in the evaluation of motor and extra-motor white matter
involvement in the early symptomatic MND, and in monitoring
the spread of pathology over time (van der Graaff et al., 2011). We
have focused our current efforts toward monitoring and estab-
lishing the nature of disease progression in the white matter via a
longitudinal study. In the future, we will aim to assess its use as
a diagnostic tool with potential value in distinguishing different
MND phenotypes.
CURRENT FINDINGS AND RELEVANCE OF PRELIMINARY DATA
Based on preliminary results presented here, including in two
patients with longitudinal scans, we demonstrate a number of fea-
tures that are consistent with pathological studies (Smith, 1960),
including presence of disease in the motor pathways (Ellis et al.,
1999; Sach et al., 2004; Iwata et al., 2008; Sage et al., 2009), IC
and CC (Filippini et al., 2010). Beyond the motor system, we
demonstrate changes in the limbic pathways (Sarro et al., 2011;
Keil et al., 2012); spread of the disease frontally (Ellis et al., 2001;
Keil et al., 2012) and potential involvement of the cerebellum (Kas-
subek et al., 2005; Keil et al., 2012). Cerebellar involvement has
been implicated in previous functional studies (Schoenfeld et al.,
2005; Konrad et al., 2006). Involvement of the CC,which connects
orbitofrontal and frontal cortices, is not surprising in ALS and has
been deemed to be a fairly consistent feature (Filippini et al., 2010).
Similarly involvement of frontal white matter and cingulum may
contribute to the cognitive symptoms in ALS patients (Abrahams
et al., 2005; Raaphorst et al., 2011; Sarro et al., 2011; Keil et al.,
2012). Cerebellar outﬂow tract involvement as seen in patient 5 has
been postulated (Schoenfeld et al., 2005; Konrad et al., 2006; Keil
et al., 2012) to be related to functional compensation; however the
exact relevance of its altered connectivity and structural impair-
ment is unclear. Although cerebellar signs are lacking in most ALS
patients, previous pathological (Swash et al., 1988) and functional
MRI studies have suggested cerebellar involvement. The implica-
tion of cerebellar involvement is typically attributed to functional
compensation in ALS rather than development of new synapses
(Schoenfeld et al., 2005).
Functional correlation in this initial dataset is difﬁcult owing to
a small current size, however in both patients 1 and 2 with longi-
tudinal scans and evidence of imaging progression of white matter
disease, there was decline in an already compromised ALSFRS-R
score. Thiswasmorepronounced inpatient 1with a longer interval
between the scans. It is noteworthy that patient 2 demonstrated
less extensive changes on the baseline scan in comparison with
other cases. This is likely related to the ﬁrst scan being undertaken
earlier in the disease course. Future analysis of the larger dataset
will shed light on a potential correlation between observed imag-
ing changes and rate of decrease in ALSFRS-R scores, including
how baseline values for functional scores relate to the initial scan.
Patient 2, for example, had a similar functional score to patient
5 with widespread white matter involvement, as seen on the con-
nectometry analysis, but had less extensive imaging changes. One
potential explanation for this is the inherent difﬁculty of corre-
lating observed imaging changes in the UMN with ALSFRS-R,
which is a composite score relying on multiple neuronal pathways
and LMN. Another explanation relates to the qualitative nature
of information derived from connectometry analysis. A further
explanation pertains to the heterogeneity in potential functional
compensation between ALS patients with similar possible dis-
ease burden. These partly explain a further need to validate the
ﬁndings from connectometry analysis with targeted tractography
approach, so that quantitative markers, for example changes in
QA may be examined in relation to functional scores. Another
ﬁnding needing future investigation is asymmetry of radiologi-
cal changes, as demonstrated here and their potential correlation
Frontiers in Human Neuroscience www.frontiersin.org April 2014 | Volume 8 | Article 270 | 8
Abhinav et al. Imaging in amyotrophic lateral sclerosis
with the clinical ﬁndings. This is observed in both patients 3 and
4, where more extensive imaging changes were found on the right
side on their baseline scan with the disease onset occurring on the
left side.
LIMITATIONS, FUTURE EXPERIMENTAL PLAN, AND DIRECTIONS
Another methodology, apparent ﬁber density (AFD; Raffelt et al.,
2012) compares the difference in ﬁber orientation distribution
and uses a clustering approach to group voxels with signiﬁcant
differences. Since the clustering is voxel-based, it does not address
differences fromdifferent ﬁberswithin the same voxel. The cluster-
ing algorithm may cluster unrelated differences. Connectometry
avoids this problem, as it is ﬁber-based, and the differences in
multiple ﬁbers are considered separately using a ﬁber skeleton.
Further, AFD is based on the spherical deconvolution method,
which is limited to HARDI, and has been shown to be subject to
CSF contamination. Our connectometry method can make use of
both the DSI and HARDI data, and the partial volume effect is
corrected using the spin density information.
One limit in the current study is the small sample size. We have
however shown that our previously presented analytical method
(Yeh et al., 2013a) may be adapted to test longitudinal data in ALS.
In this respect, the current study presents preliminary results. The
40-min DSI scan can now be replaced by multi-band DSI sequence
(Sotiropoulos et al., 2013), which takes less than 10 min to acquire
half sphere 101-directions DSI. This will dramatically improve the
clinical applicability of this method, particularly for patients with
neurodegenerative disorders. We are currently in the process of
deploying this sequence for scanning new patients.
In addition to the previously mentioned details, we will exam-
ine the relationship between clinical and imaging progression on
connectometry analysis. We will further corroborate the ﬁndings
from connectometry analysis by performing targeted analysis of
the affected tracts beyond CST for example, cingulum or thalamo-
postcentral ﬁbers. We will therefore, aim to further identify tracts,
that may be preferentially affected and calculate the changes in the
associated quantitative markers. The changes in these will be cor-
related with the rate of disease progression, for example drop in
ALSFRS-R scores with change in CST or decline in ALS cognitive
behavioral screen with change in cingulum. In future work, we
will need to establish a normal range of expected variability in QA
and/or volumes for ﬁber tracts of interest between scan sessions
for comparison with observed changes in affected ﬁbers. Although
with disease progression, a decrease in mean QA will be expected
for a speciﬁc ﬁber tract of interest, the increase as observed for
a few tracts (Table 1) can be either explained by the variability
in QA across scan sessions or potential functional compensation
of the remaining ﬁbers. This remains to be elucidated further in
the future. Similarly, variability issues with respect to the calcu-
lated volumes may accentuate the extent of the ﬁndings in terms
of disease progression. This may explain the large noted percent-
age decrease in the volume of the callosal ﬁbers in patient 1. We
will also explore and establish an optimal length threshold and the
associated FDR for ALS patients, particularly in relation to our
matched control dataset.
One of the endeavors associated with DTI in ALS has been
evaluation of its use as a diagnostic tool and as an aid enabling
discrimination between different MND phenotypes. A recent
meta-analysis (Foerster et al., 2013) concluded that DTI analysis
in ALS only had modest discriminatory capability. Further, there
were no signiﬁcant differences in the diagnostic test accuracy esti-
mates with respect to MRI ﬁeld strength or brain location. Poten-
tial reasons for this poor result may be the clinico-pathological
heterogeneity in ALS, and use of group studies. These issues
become even more pertinent in the context of different MND
phenotypes. Although there is increasing evidence that the differ-
ent MND phenotypes lie within a spectrum (van der Graaff et al.,
2011;Agosta et al., 2014)with overlappingwhitematter abnormal-
ities, the anatomical location and the extent of these changes vary,
making group comparisons difﬁcult. This is the primary reason
we have focused on ALS patients’ individual progression and have
started by exploring the nature, extent and distribution of ﬁnd-
ings from the connectometry analysis. Having established these
we will embark upon further studies applicable toward diagnos-
ing and differentiating between different MND phenotypes. This
could be achieved, for example, by using the varying anatomical
(rostro-caudal) and quantitative involvement of CST as a guide.
In conclusion, we have presented preliminary results, using DSI
in longitudinal evaluation of white matter pathology in ALS, as a
ﬁrst step toward developing an imaging biomarker to monitor
disease progression. We ultimately intend to establish an imag-
ing biomarker capable of evaluating efﬁcacy of novel therapies in
slowing or reversing the disease progression.
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